Table 1. Stricture free rates after prostate cancer therapy.
| Primary treatment | 6 Months | 1 Year | 2 Years | 4 Years |
|---|---|---|---|---|
| RP | 93 (92–94) | 91 (90–93) | 91 (89–92) | 89 (86–91) |
| RP+EBRT | 97 (88–99) | 95 (85–98) | 95 (85–98) | 86 (46–97) |
| Cryotherapy | 96 (92–98) | 96 (92–98) | 95 (89–98) | 87 (66–95) |
| BT | 96 (94–97) | 94 (92–96) | 93 (90–95) | 89 (80–94) |
| BT+EBRT | 96 (92–98) | 92 (87–95) | 88 (91–93) | 84 (71–92) |
| EBRT | 99 (97–99) | 98 (96–99) | 96 (93–97) | 95 (90–98) |
| Hormones | 96 (94–97) | 94 (92–96) | 93 (90–95) | 92 (87–95) |
| WW | 99 (97–100) | 99 (97–100) | 98 (95–99) | 93 (68–99) |
Values are presented as % stricture treatment free (95% confidence interval).
RP, radical prostatectomy; EBRT, external beam radiotherapy; BT, brachytherapy; WW, watchful waiting.
Adapted from Elliott et al. J Urol 2007;178:529–34, with permission of Elsevier [19].